Oruka Therapeutics, Inc. (ORKA)
NASDAQ: ORKA · Real-Time Price · USD
40.00
+8.01 (25.04%)
At close: Mar 13, 2026, 4:00 PM EDT
40.40
+0.40 (1.00%)
Pre-market: Mar 16, 2026, 7:35 AM EDT
Oruka Therapeutics Employees
Oruka Therapeutics had 68 employees as of December 31, 2025. The number of employees increased by 40 or 142.86% compared to the previous year.
Employees
68
Change (1Y)
40
Growth (1Y)
142.86%
Revenue / Employee
n/a
Profits / Employee
-$1,239,853
Market Cap
1.98B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 68 | 40 | 142.86% |
| Dec 31, 2024 | 28 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Zai Lab | 1,784 |
| Ultragenyx Pharmaceutical | 1,371 |
| Adaptive Biotechnologies | 624 |
| Galapagos NV | 558 |
| Ocular Therapeutix | 325 |
| Syndax Pharmaceuticals | 298 |
| Celldex Therapeutics | 198 |
| Stoke Therapeutics | 128 |
ORKA News
- 3 days ago - Oruka Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update - GlobeNewsWire
- 18 days ago - Oruka Therapeutics: A Potential Future Psoriasis Play - Seeking Alpha
- 5 weeks ago - Oruka Therapeutics to Participate in Multiple Upcoming Conferences - GlobeNewsWire
- 2 months ago - Oruka Therapeutics Announces Positive Interim Phase 1 Data for ORKA-002 and Initiation of EVERLAST-B Trial of ORKA-001 - GlobeNewsWire
- 2 months ago - Oruka Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference - GlobeNewsWire
- 2 months ago - Oruka Therapeutics: ORKA-001 For Psoriasis In Focus As 2026 Phase 2 Data Nears - Seeking Alpha
- 3 months ago - Oruka Therapeutics Announces New Board Member and Board Transition - GlobeNewsWire
- 4 months ago - Oruka Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update - GlobeNewsWire